EEPD1 Deficiency Drives Diabetic Kidney Disease Progression via Amplified Genotoxic Stress and Downregulation of EHHADH
Journal of Molecular Cell Biology · 10.11.2026
DOI: 10.1093/jmcb/mjag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 10.11.2026. Verfasst von Qian Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic kidney disease (DKD), a major microvascular complication of diabetes, is characterized by oxidative stress and chronic inflammation that collectively promote cellular DNA damage and tubular injury. Although these pathological mechanisms are well recognized, the contribution of DNA repair enzymes to DKD progression remains largely unexplored. Here, we identify endonuclease/exonuclease/phosphatase family domain-containing 1 (EEPD1), a key DNA damage response enzyme, as a novel renoprotective factor in DKD. We found that EEPD1 protein abundance was significantly reduced in the kidneys of high-fat diet/streptozotocin (HFD/STZ)-induced diabetic mice and db/db mice (two widely used murine models of DKD) and in human proximal tubular epithelial cells (HK-2) exposed to high glucose. Genetic ablation of Eepd1 in mice exacerbated renal injury, fibrosis, and dysfunction in both HFD/STZ-induced and HFD-induced diabetic models. Transcriptomic and biochemical analyses revealed that Eepd1 deficiency promoted DNA damage accumulation, inflammatory activation, and metabolic dysregulation, particularly through suppression of the peroxisomal fatty acid oxidation (FAO) enzyme EHHADH, at both mRNA and protein levels. Integrated transcriptional analyses and functional validation further identified PPARα as a critical transcriptional mediator linking EEPD1 to EHHADH regulation. Mechanistically, EEPD1 deficiency reduced PPARα expression, whereas PPARα depletion impaired EEPD1-dependent activation of EHHADH expression and promoter activity. Collectively, our findings identify an EEPD1–PPARα–EHHADH regulatory axis that connects DNA repair with peroxisomal metabolic homeostasis and establishes EEPD1 as a potential therapeutic target for DKD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Emergency Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China.
- Department of Nephrology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Zhou, Q., Qian, Q., Yin, L., Jiang, Q., Xu, Y., Liu, A., Zheng, L., Yin, H., Han, L., Sheng, L., Li, Y., Zhou, P., & Chen, S. (2026). EEPD1 Deficiency Drives Diabetic Kidney Disease Progression via Amplified Genotoxic Stress and Downregulation of EHHADH. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjag048
Vancouver
Zhou Q, Qian Q, Yin L, Jiang Q, Xu Y, Liu A, et al. EEPD1 Deficiency Drives Diabetic Kidney Disease Progression via Amplified Genotoxic Stress and Downregulation of EHHADH. Journal of Molecular Cell Biology. 2026. doi:10.1093/jmcb/mjag048
BibTeX
@article{Zhou2026,
author = {Zhou, Qian and Qian, Qiqi and Yin, Limin and Jiang, Quanxin and Xu, Ying and Liu, Anran and Zheng, Liaoyuan and Yin, Hanrui and Han, Liu and Sheng, Lulu and Li, Yongxia and Zhou, Peihui and Chen, Suzhen},
title = {EEPD1 Deficiency Drives Diabetic Kidney Disease Progression via Amplified Genotoxic Stress and Downregulation of EHHADH},
journal = {Journal of Molecular Cell Biology},
year = {2026},
doi = {10.1093/jmcb/mjag048}
}
EUVIMED